The First-Day Verdict Got Marvell's Last Two Big Deals Backwards. Lumentum Is the One Its Playbook Does Not Cover.
Marvell's Reported Lumentum Talks Target the Laser That CPO Cannot Remove. The Bet Is That Lasers Stay Scarce.
